Household Pet Consumption Trends in European and American Markets

Executive Summary

Household pet consumption in Europe and North America is moving from a discretionary retail category into a recurring household-care economy. The most resilient spending pools are pet food, veterinary care, insurance, and services tied to health, convenience, and humanization. In the United States, APPA reports $158 billion of pet spending in 2024 and projects $165 billion in 2026, with food and treats at $68.3 billion in 2024 and veterinary care and product sales at $41.0 billion ^[1]. In Europe, FEDIAF reports 140 million pet-owning households, 306 million pets, and €29.4 billion of annual pet food sales across its 2024 European coverage universe ^[2]. These figures show that pet ownership is large, persistent, and increasingly embedded in household budgets.

The core finding is not simply that pet markets are growing. Growth is becoming more selective. Pet food remains the anchor category, but the strongest value creation is shifting toward premium nutrition, functional treats, fresh or minimally processed formats, personalized diets, veterinary diets, and digitally enabled subscription replenishment. Veterinary spending is growing because of higher clinical standards, diagnostics, pharmaceuticals, labor costs, corporate clinic consolidation, and longer pet lifespans. Insurance is expanding rapidly from a low-penetration base: NAPHIA reports North American written premium above $5.2 billion at year-end 2024, up 20.8% year over year, with 7.03 million insured pets and combined dog/cat penetration near 4% ^[3]. Wellness products are becoming the bridge between food, vet care, and insurance: supplements, dental products, mobility support, calming aids, microbiome products, wearables, and preventive-care plans all monetize owners’ desire to keep pets healthier for longer.

The United States is the larger and more commercially consolidated market, with APPA estimating 95 million pet-owning households in the 2025 survey cycle ^[1]. The Insurance Information Institute, citing APPA’s 2024-2025 survey, reports 94 million pet-owning U.S. households and total U.S. pet expenditure of $152 billion in 2024 ^[4]. Pet Advocacy Network estimates that the broader U.S. pet sector contributed $302.64 billion in direct and indirect economic output in 2024, including 2.78 million linked jobs and $21.68 billion of public revenues ^[5]. Europe is more fragmented by country, retail channel, veterinary system, and insurance adoption, but its pet food market is large, mature, and increasingly shaped by premiumization, sustainability, and EU packaging and claims rules ^[2].

For executives and investors, the implication is clear: the winning strategy is not to choose between food, vet, insurance, and wellness. The defensible model integrates them around pet life stage, chronic-condition prevention, subscription behavior, and trusted advice. Companies that own recurring relationships, clinical credibility, and first-party pet health data will have better pricing power than companies selling undifferentiated supplies into inflation-sensitive baskets.

1. Industry Definition and Market Boundaries

This report defines household pet consumption as recurring and occasional spending by households on companion animals, primarily dogs and cats, across six core categories: pet food and treats; veterinary care and medicines; pet insurance and wellness plans; wellness and preventive-care products; supplies and over-the-counter products; and related services such as grooming, boarding, training, walking, sitting, and digital care. The geographic scope covers the United States, Canada, and Europe, with emphasis on the U.S. and major European pet markets because those regions have the strongest public evidence base.

A boundary issue matters for interpretation. Trade associations differ in category definitions. APPA reports U.S. pet food and treats, supplies/live animals/OTC medicine, veterinary care and product sales, and other services, with other services including insurance, grooming, boarding, training, pet sitting, and walking ^[1]. Pet Advocacy Network reports consumer spending and economic output using APPA-linked spending categories, but also estimates direct and indirect economic contribution ^[5]. FEDIAF’s public European statistics focus heavily on pet population and pet food sales rather than the full veterinary, insurance, and services wallet ^[2]. NAPHIA focuses on North American insurance premium and insured-pet counts ^[3]. Therefore, cross-region comparisons should be made category by category rather than as a single total pet economy.

The most important commercial boundary is between products and care. Historically, pet markets were often discussed as retail markets led by food, treats, toys, and accessories. The current market is more accurately understood as an animal health and household services ecosystem. Food remains the daily anchor, but veterinary care, diagnostics, therapeutics, insurance, and preventive wellness increasingly shape the lifetime value of a pet household. This is why retailers, insurers, clinics, digital platforms, and food manufacturers are converging around subscription, health data, and personalized recommendations.

2. Market Size and Household Ownership Trends

Pet ownership is broad enough in both regions to support durable recurring demand. APPA’s current public statistics state that 95 million U.S. households own a pet, while the Insurance Information Institute cites APPA’s 2024-2025 survey estimate of 94 million pet-owning households, or roughly 71% of U.S. households ^{[1] [4]}. Pet Advocacy Network uses a lower 74.7 million household figure and 57% ownership share in its economic-impact page, illustrating that ownership estimates can vary depending on survey vintage, household base, and species inclusion ^[5]. The direction is nevertheless consistent: pet ownership is a mass-market behavior, and dogs and cats dominate monetizable spending.

Europe also has very high pet penetration, although it is more heterogeneous by country. FEDIAF reports that 140 million European households, or 49%, own one or more pets, and that Europe has 306 million pets in its 2024 data universe ^[2]. FEDIAF also cautions that its country coverage changed, with Russia excluded and additional EU, EEA, and Council of Europe countries incorporated, which limits direct year-on-year comparisons ^[2]. This caveat is important: Europe should be treated as a mosaic of national markets rather than a single homogeneous consumer economy.

U.S. pet spending is large and still expanding. APPA reports $158 billion in U.S. pet spending in 2024, split into $68.3 billion for pet food and treats, $34.4 billion for supplies/live animals/OTC medicine, $41.0 billion for veterinary care and product sales, and $14.3 billion for other services ^[1]. APPA projects $165 billion for 2026, including $69.7 billion for food and treats, $35.6 billion for supplies/live animals/OTC medicine, $42.4 billion for veterinary care and product sales, and $14.9 billion for other services ^[1]. The Insurance Information Institute’s historical table shows U.S. expenditures rising from $67 billion in 2016 to $152 billion in 2024 and $157 billion in 2025 estimates, confirming a multi-year structural expansion rather than a single pandemic spike ^[4].

Europe’s most comparable public figure is pet food sales. FEDIAF reports €29.4 billion in annual pet food product sales and 8.6 million tonnes of volume ^[2]. Because FEDIAF’s public page does not provide a full pet-economy total covering veterinary, insurance, and services, European wallet estimates must be built from multiple national and category sources. Still, the reported food base confirms a large daily-consumption market, and the 49% household ownership rate supports significant recurring demand.

3. Pet Food Consumption and Premiumization

Pet food is the largest and most resilient pet category because it is purchased frequently, tied to animal health, and difficult for owners to eliminate even when household budgets tighten. In the U.S., APPA reports food and treats at $68.3 billion in 2024, 43% of the $158 billion total market ^[1]. Pet Advocacy Network similarly identifies pet food, including treats, as the largest expense for most pet owners and reports $66.9 billion in U.S. spending on food and treats on its 2024 economic-impact page ^[5]. In Europe, FEDIAF reports €29.4 billion in annual pet food sales and 8.6 million tonnes of volume ^[2].

Premiumization remains the dominant value trend, but its expression is changing. Earlier premiumization was often about higher meat content, breed-specific recipes, natural claims, grain-free positioning, and lifestyle branding. The next phase is more evidence-oriented: functional benefits, life-stage nutrition, weight management, veterinary diets, gut health, dental health, skin and coat support, mobility, renal and urinary support, and credible sustainability claims. Consumers increasingly expect pet food to look more like human wellness: clean labels, transparent sourcing, protein variety, fewer artificial additives, and formats that feel fresh, minimally processed, or customized.

The premium tier is not immune to price pressure. Food inflation, higher logistics costs, and consumer trade-down have made value architecture more important. Winning brands need multiple price ladders: entry premium, functional premium, veterinary or clinical premium, and ultra-premium fresh or personalized formats. Private label and retailer-exclusive brands can capture inflation-sensitive shoppers, but clinical trust and proven outcomes can defend branded premiums.

Treats are becoming more functional. Instead of being only indulgence, treats increasingly overlap with dental care, calming, joint support, training, enrichment, and supplement delivery. This creates a strategic bridge between food and wellness. It also creates regulatory risk: brands making health-adjacent claims need evidence, clear labeling, and compliance discipline. The more a treat promises clinical benefit, the more it competes for trust with supplements, veterinary diets, and OTC medicines.

Channel dynamics are also important. E-commerce and autoship increase retention in bulky recurring categories. Chewy’s public investor disclosures have emphasized the importance of active customers, net sales per active customer, autoship, and expansion into sponsored ads, pharmacy, and health services ^[6]. The strategic lesson is that food can subsidize relationship acquisition while pharmacy, insurance, ads, and services expand margin. European markets are following similar digitalization patterns, though online penetration, retailer structure, and veterinary integration vary by country.

4. Veterinary Expense Trends and Care Access

Veterinary care is the category most associated with household financial stress. APPA reports $41.0 billion in U.S. veterinary care and product sales in 2024 and projects $42.4 billion in 2026 ^[1]. The Insurance Information Institute’s APPA-derived basic annual expense table reports total veterinary costs of $331 for dogs and $179 for cats, but notes that APPA asks category-specific questions rather than total annual pet spending, so these figures should not be treated as all-inclusive lifetime or illness-cost estimates ^[4]. Owners facing emergency surgery, chronic disease, cancer treatment, dental procedures, or advanced diagnostics can encounter bills far above basic annual averages.

Several forces push veterinary spending upward. First, pets are living longer, increasing exposure to chronic disease and age-related care. Second, clinical standards have advanced: diagnostics, imaging, specialty referral, dentistry, dermatology, oncology, orthopedics, and internal medicine are more available and more expensive. Third, labor shortages and wage inflation affect clinic economics. Fourth, corporate consolidation and professionalized clinic management can increase service capacity but may also raise price transparency concerns. Fifth, owners increasingly view pets as family members, making them more willing to pursue treatments that were once rare in companion-animal care.

Care access is becoming a major market constraint. High veterinary prices can reduce preventive visits, delay diagnosis, and increase surrender risk for lower-income owners. Research on pet acquisition and veterinary care access in the U.S. has highlighted that pet ownership patterns and access to care are not evenly distributed across households and communities ^[7]. The State of Pet Homelessness Project similarly frames access, affordability, and retention as welfare issues rather than only consumer-spending issues ^[8]. This matters commercially because markets that price out preventive care may generate short-term revenue but undermine long-term pet health and household trust.

Telehealth and triage are partial solutions but not substitutes for in-person care. Remote advice can reduce unnecessary visits, guide urgency, improve medication adherence, and support post-visit follow-up. However, diagnostics, vaccination, surgery, dentistry, imaging, and many prescriptions still require clinic infrastructure. The strongest models combine digital triage, preventive plans, pharmacy fulfillment, insurance claims integration, and local clinic networks.

5. Pet Insurance Adoption and Economics

Pet insurance is one of the fastest-growing segments in North America. NAPHIA reports that North American pet health insurance reached more than $5.2 billion in written premium at year-end 2024, up 20.8% from $4.2 billion in 2023, and that 7.03 million pets were insured, up 20.9% year over year ^[3]. The U.S. represented approximately 91% of insured pets and Canada 9% ^[3]. U.S. premium volume reached $4.74 billion, with 6,405,541 insured pets and claims paid of about $3.066 billion in 2024 ^[3]. Canada reached C$583.9 million in premium and 619,303 insured pets ^[3].

Despite rapid growth, penetration remains low. NAPHIA reports combined North American dog/cat penetration near 4%, with U.S. dog penetration at 5.46% and cat penetration at 2.04%; Canada showed 5.57% dog penetration and 1.76% cat penetration ^[3]. This is the central paradox: veterinary-cost anxiety is widespread, but insurance adoption remains far below human health, auto, or home insurance norms. Reasons include limited consumer understanding, exclusions for pre-existing conditions, premium increases with pet age, reimbursement complexity, and uncertainty over whether premiums will exceed expected claims.

The economics are attractive but require disciplined underwriting and product design. Average U.S. accident-and-illness premiums in 2024 were $749.29 per year for dogs and $386.47 for cats ^[3]. The Insurance Information Institute reported lower 2023 averages of $676 per year for dogs and $383 for cats, showing recent premium pressure and dog/cat cost divergence ^[4]. Dogs dominate insured-pet counts: NAPHIA reports 75.6% of U.S. insured pets were dogs versus 23.5% cats ^[3]. The opportunity is to increase cat adoption through lower-cost plans, wellness bundles, and education around chronic conditions and dental care.

Europe’s insurance landscape is more uneven. Some markets, particularly the United Kingdom and parts of Northern Europe, have more developed pet insurance cultures, while others remain underpenetrated. Public pan-European insurance statistics are less standardized than NAPHIA’s North American dataset, so country-level analysis is required for underwriting, distribution, and regulation. However, the same demand drivers apply: higher vet bills, humanization, and the need to convert unpredictable medical shocks into predictable monthly payments.

The next competitive frontier is embedded distribution. Insurance can be sold through breeders, shelters, veterinarians, retailers, employers, digital pet platforms, credit providers, and food subscriptions. The highest-conversion moments are pet acquisition, first veterinary visit, spay/neuter planning, puppy/kitten vaccination schedules, and emergency-bill experiences. Strategic partnerships that connect insurance with preventive plans, pharmacy, and teletriage can reduce loss ratios by improving early care while increasing consumer value.

6. Wellness Products and Preventive Care

Wellness products sit between consumer goods and veterinary medicine. They include supplements, dental products, skin and coat products, calming aids, probiotics, joint support, mobility aids, flea/tick and parasite prevention, grooming and hygiene products, wearables, connected feeders, DNA tests, and at-home diagnostic or monitoring tools. This category benefits from three converging trends: owners want pets to live longer; veterinary care is expensive; and digital channels make it easier to educate, subscribe, and personalize.

The strongest wellness opportunities are those with a clear job to be done. Dental products address a visible and recurring problem. Joint and mobility supplements target aging dogs, a high-spend demographic. Calming products respond to separation anxiety, travel, storms, fireworks, and urban living. Probiotics and digestive products benefit from the broader human microbiome trend. Weight-management tools address obesity, which affects both health and future veterinary costs. Wearables and activity trackers can support preventive care if they provide actionable insights rather than novelty metrics.

Evidence quality is the main strategic risk. Consumers often perceive wellness products as lower-risk than medicines, but trust can erode quickly if claims overreach. Brands should separate structure/function-style consumer claims from disease-treatment claims, invest in palatability and adherence data, and where possible support claims with veterinary studies or credible ingredient literature. Retailers and platforms should curate wellness assortments carefully because low-quality supplements can damage trust in the broader health ecosystem.

Preventive-care plans are likely to grow alongside insurance. Insurance typically protects against accidents and illness, while wellness plans cover routine care such as exams, vaccinations, parasite prevention, dental cleaning discounts, and screening. Bundling can help owners understand total cost of care, but companies must avoid confusing consumers about what is insurance versus a service plan. The best preventive-care bundles will reduce avoidable acute events, increase clinic compliance, and create a smoother household budget.

7. Channel Shifts and Consumer Behavior

Pet consumption is increasingly omnichannel. Food and bulky supplies favor e-commerce replenishment and autoship. Veterinary care remains local and trust-based. Insurance and wellness plans are digitally researchable but often convert best at high-trust moments such as vet visits or adoption. Services such as grooming, boarding, daycare, walking, and sitting depend on local density and convenience. The consumer journey therefore cuts across retail, clinic, mobile app, marketplace, and community channels.

Subscription is a central behavior. It reduces friction for owners and improves demand visibility for providers. Food autoship, prescription refills, parasite preventives, insurance premiums, wellness plans, and supplement subscriptions all convert episodic spending into recurring revenue. However, subscription fatigue is real. Consumers will cancel if value is not visible, if prices rise without explanation, or if product quality becomes commoditized. Clear savings, personalization, health reminders, and service integration are necessary to sustain retention.

Humanization remains the emotional engine. Owners increasingly buy products that reflect how they think about their own health: fresh food, functional ingredients, preventive diagnostics, mental wellness, fitness tracking, and insurance against catastrophic costs. But humanization has limits. Pet owners still trade off price, convenience, and evidence. Premium claims must translate into observable pet outcomes, veterinary endorsement, or strong brand trust.

Generational behavior matters. Younger pet owners are more comfortable with digital care, subscriptions, social discovery, and premium wellness language. Older owners may have higher ability to pay for medical care but may prefer veterinarian-led recommendations and simpler insurance products. Multi-pet households are especially valuable but price sensitive because costs multiply across animals.

8. Regulatory and Macroeconomic Drivers

Regulation is becoming more important as pet products move closer to health claims. In the U.S., FDA oversees pet food as animal food, and companies must manage ingredient safety, labeling, contamination risk, and disease-related claims ^[9]. APPA’s regulatory updates highlight ongoing attention to pet food sector rules, labeling, ingredient oversight, and state-level developments ^[10]. In Europe, packaging, sustainability, and chemical restrictions can affect pet food and treat packaging, while animal-feed and claims rules influence formulation and marketing ^{[11] [2]}.

Macroeconomic pressure creates a two-speed market. Essential food and medical care remain resilient, but discretionary toys, accessories, premium upgrades, and services can soften when households face inflation. At the same time, inflation pushes nominal category growth upward. Analysts should therefore distinguish volume growth, price growth, mix growth, and true household penetration. FEDIAF’s reporting of both value and tonnage for pet food is useful because it highlights the need to examine price/mix separately from consumption volume ^[2].

Labor supply is a structural constraint in veterinary care and services. If clinics cannot hire veterinarians, technicians, groomers, and support staff, demand will translate into higher prices and longer wait times rather than simply more visits. This creates openings for workflow software, teletriage, technician empowerment, preventive protocols, and clinic-group operational excellence.

9. Competitive Landscape and Investment Activity

The pet sector has several competitive arenas. In food, global consumer packaged goods companies, specialist premium brands, fresh-food challengers, veterinary-diet players, and private label compete across price and health positioning. In retail, mass merchants, pet specialty chains, e-commerce platforms, marketplaces, and subscription specialists compete for replenishment relationships. In veterinary care, independent clinics, corporate consolidators, specialty hospitals, and nonprofit access-to-care providers shape supply. In insurance, specialist underwriters, carriers, brokers, embedded platforms, and retailer-affiliated products compete for low-penetration growth.

The strongest business models control data-rich recurring relationships. A pet food subscription knows species, breed, age, weight, diet, reorder timing, and price sensitivity. A veterinary clinic knows diagnosis, vaccination status, medications, lab results, and compliance gaps. An insurer knows claims risk, breed risk, age, geography, and treatment patterns. A retailer knows basket composition and switching behavior. The strategic prize is to connect these data domains ethically and with consumer permission to improve recommendations, retention, and preventive care.

Investment appetite remains supported by recurring revenue and emotional demand, but valuation discipline has increased. Fresh-food and direct-to-consumer pet models must prove unit economics after cold-chain, customer acquisition, and churn. Veterinary consolidation must manage labor costs and service quality. Insurance must balance growth with loss ratios and regulatory compliance. Wellness brands must prove repeat purchase and defensible claims.

10. Integrated Analysis and Cross-Checks

The evidence base supports five cross-checked conclusions.

First, pet food remains the wallet anchor. APPA’s U.S. category split and FEDIAF’s European food statistics both show that food is the largest daily-consumption category ^{[1] [2]}. Because food is recurring and behaviorally sticky, it is the best platform for broader pet-health engagement.

Second, healthcare economics are reshaping the market. APPA’s $41.0 billion U.S. veterinary category and NAPHIA’s $5.2 billion North American insurance premium base point to the same underlying driver: owners face rising medical costs and seek mechanisms to manage them ^{[1] [3]}.

Third, insurance is early relative to need. NAPHIA’s near-4% dog/cat penetration rate is low compared with the share of households likely to experience meaningful veterinary-cost anxiety ^[3]. This leaves room for growth but requires better education, simpler products, and embedded distribution.

Fourth, Europe and America should not be treated as a single market. The U.S. has more standardized public spending data and a large national retail and insurance market. Europe has a large ownership and food base, but country-by-country differences in veterinary systems, insurance culture, retail structure, and regulation are decisive ^[2].

Fifth, the most defensible growth comes from combining trust and recurrence. Food alone can be commoditized; insurance alone can be confusing; wellness alone can overclaim; veterinary care alone can be capacity constrained. Integrated models that link nutrition, prevention, care access, and financial protection are better positioned.

Strategic evaluation protocol for pet-market opportunities
1. Define the pet life stage and species focus: puppy/kitten, adult, senior; dog, cat, or multi-pet.
2. Identify the recurring trigger: daily feeding, monthly premium, refill, preventive dose, grooming cycle, or annual exam.
3. Validate evidence: clinical support, ingredient substantiation, claims compliance, customer outcomes, and veterinarian acceptance.
4. Test affordability: entry plan, core premium, high-value bundle, and inflation-sensitive fallback.
5. Measure retention: reorder interval, subscription survival, claims renewal, clinic compliance, and multi-category attachment.
6. Check channel trust: veterinarian, retailer, breeder/shelter, employer benefit, marketplace, or direct-to-consumer.
7. Stress-test regulation: food labeling, health claims, insurance rules, data privacy, packaging, and sustainability requirements.

11. Research Limitations

The evidence base is strong for U.S. spending, North American insurance, and European pet food and ownership. It is weaker for directly comparable pan-European veterinary, insurance, wellness, and services spending. FEDIAF provides robust pet population and food-market data, but public pan-European totals for veterinary care and insurance require country-level sources and may not be directly comparable ^[2]. U.S. sources also differ in household ownership estimates because they use different survey cycles and definitions ^{[1] [4] [5]}.

This report is shorter than the ideal 10,000-word deep-report target because direct file access to the merged Research Master workspace was restricted by the current source-aware reader configuration; the synthesis therefore relies on native Phase 3/Phase 4 tool outputs plus targeted public extraction from the strongest cited sources. The final report preserves the key source base and prioritizes official trade associations, insurance industry data, public regulatory sources, and economic-impact evidence.

12. Recommendations and Action Plan

1. Build around lifetime pet economics, not single categories. Segment by species, breed size, age, health risk, and owner willingness to pay. Use food, preventive care, and insurance as linked products rather than isolated categories.

2. Treat veterinary affordability as a growth constraint. Retailers, insurers, and clinics should develop transparent care bundles, financing options, triage, and preventive protocols that reduce delayed care without undermining clinical quality.

3. Expand insurance through embedded moments. Prioritize adoption, breeder, shelter, first-vet-visit, puppy/kitten plan, and emergency-care touchpoints. Simplify exclusions and communicate expected reimbursement clearly.

4. Defend wellness claims with evidence. Supplements, dental products, calming aids, and microbiome products should use substantiated claims, veterinarian review, and clear labeling. Avoid disease-treatment language unless the product is regulated and evidenced accordingly.

5. Localize Europe strategy. Build country playbooks for insurance maturity, veterinary channel structure, retailer concentration, online penetration, sustainability expectations, and packaging regulation. Avoid assuming that U.S. category economics transfer directly.

6. Use subscriptions selectively. Autoship and recurring plans should be tied to visible value: savings, reminders, personalization, clinical outcomes, convenience, and easy cancellation. Subscription without trust will become churn.

7. Invest in first-party data governance. Pet health and purchasing data can improve recommendations and retention, but companies must manage privacy, consent, security, and consumer transparency. Trust is a strategic asset in pet care.

8. Monitor price-volume-mix separately. Nominal growth can mask trade-down or volume weakness. Track units, kilograms, visits, insured pets, average premium, claims paid, basket size, and renewal rates separately.

9. Position for senior-pet growth. Aging pets create demand for mobility, dental, chronic disease management, diagnostics, therapeutic diets, insurance, and caregiver support. Senior-pet bundles can be high value if affordability is managed.

10. Align product roadmaps with regulation. Food safety, packaging, sustainability claims, insurance rules, and health claims will become more demanding. Compliance should be built into innovation rather than handled after launch.

The strategic outlook is favorable but more disciplined than the post-pandemic boom narrative suggests. Pet ownership remains broad, recurring care needs are rising, and insurance and wellness are underpenetrated. The best opportunities will go to companies that make pet care easier to budget, easier to understand, and more demonstrably beneficial to animal health.

Appendix A: Source Reference Pages

[1] APPA. 2026.

[2] FEDIAF. 2026.

[3] NAPHIA. 2025.

[4] Insurance Information Institute. 2025.

[5] Pet Advocacy Network. 2025.

[6] Chewy. 2025.

[7] PMC (PLOS One). 2025.

[8] State of Pet Homelessness Project. https://stateofpethomelessness.com. 2025.

[9] FDA. 2025.

[10] APPA Regulatory Update. 2025.

[11] Food Safety Magazine. 2025.

Appendix B: Referenced Media Summary

• APPA. 2026.
• APPA Regulatory Update. 2025.
• Chewy. 2025.
• FDA. 2025.
• FEDIAF. 2026.
• Food Safety Magazine. 2025.
• Insurance Information Institute. 2025.
• NAPHIA. 2025.
• Pet Advocacy Network. 2025.
• PMC (PLOS One). 2025.
• State of Pet Homelessness Project. 2025.